SPOTLIGHT -
Healthcare authorities must be updated on AMD and the importance of new therapies. A system also needs to be implemented which advises on responsibility for payment.
Amniotic membrane could move the needle outside of the operating room
The tissue serves as a testing ground for outpatient ocular therapies
Novel Therapies in Neovascular AMD and DME: Achieving Superior Anatomic Outcomes with Fewer Injections
SCHWIND appoints new head of global marketing solutions
Lohith Shetty will lead marketing for the company, based in Kleinostheim, Germany
Long-Term Efficacy and Durability of Latest Therapies in neovascular AMD and DMO
Cataract surgery pre-treatment with miLoop: Shorter lensectomy time, less irrigation needed
Investigators presented research on the pre-treatment outcomes during the 2024 ASCRS meeting
To Infinity and (PRES)BYOND - The game changer for my practice